Sandy Spring Bank’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$162 Hold
33
﹤0.01% 1174
2024
Q4
$276 Sell
33
-1
-3% -$9 ﹤0.01% 1157
2024
Q3
$351 Hold
34
﹤0.01% 1135
2024
Q2
$665 Hold
34
﹤0.01% 1177
2024
Q1
$864 Hold
34
﹤0.01% 1123
2023
Q4
$932 Buy
34
+1
+3% +$61 ﹤0.01% 1080
2023
Q3
$2.03K Buy
+33
New +$2.32K ﹤0.01% 1027
2023
Q2
Hold
0
1226
2023
Q1
Hold
0
1161
2022
Q4
Hold
0
1140
2020
Q3
Sell
-3
Closed -$2K 935
2020
Q2
$2K Buy
+3
New +$2.26K ﹤0.01% 825
2016
Q3
Sell
-51
Closed -$29K 839
2016
Q2
$29K Buy
+51
New +$28.9K ﹤0.01% 521

Other funds holding BLUE

Sandy Spring Bank's BLUE Position: Q1 2025 in Review

Sandy Spring Bank held its bluebird bio (BLUE) position steady in Q1 2025 at 33 shares worth $162. The position accounts for ﹤0.01% of the portfolio, ranked #1174.

Sandy Spring Bank first reported a position in BLUE in Q2 2016 and has held it in 9 quarters since. The position peaked at $29K in Q2 2016. 85 funds tracked by Wall St. Rank hold BLUE as of Q1 2025.

  • Sandy Spring Bank held 33 shares of bluebird bio worth $162 as of Q1 2025.
  • Sandy Spring Bank left its bluebird bio share count unchanged in Q1 2025.
  • bluebird bio made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #1174 holding.
  • Sandy Spring Bank first reported a position in bluebird bio in Q2 2016 and has held it in 9 quarters since.
  • Sandy Spring Bank's bluebird bio position peaked at $29K in Q2 2016.
  • 85 funds tracked by Wall St. Rank held bluebird bio as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.